Netherlands· NL-d5aaa048683d

Duspatal Retard 200 mg, capsules met gereguleerde afgifte

A mebeverine product containing mebeverinehydrochloride, registered in Netherlands by Abbott B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC A03AA04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mebeverinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Mebeverine is registered in 13 of 19 countries.

Countries holding a registration under ATC A03AA04 (mebeverine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search mebeverine products by name

Mebeverine · ATC A03AA04

13 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mebeverine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.20 in France to $1.31 in Switzerland — a ×6.5 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Mebeverine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

CH Switzerland$1.31
FR France$0.20

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MEBEVERINEHYDROCHLORIDE
Manufacturer: Abbott B.V.
Country: Netherlands (NL)
ATC code: A03AA04
ATC class: Mebeverine
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
11657

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mebeverine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mebeverine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Colofac, Colofac Retard
Belgium · Duspatalin, Duspatalin Retard
Bulgaria · Дуспаверин, Дуспаталин
Cyprus · Medoverine, Spasverin
Czechia · Duspatalin Retard
Germany · Duspatal, Duspatal Retard
Denmark · Duspatalin Retard
Estonia · Mebeverine Sanoswiss
Spain · Duspatalin, Mebeverina Tarbis
France · Duspatalin, Mebeverine Zentiva
United Kingdom (Northern Ireland) · Aurobeverine Mr, Boots Ibs Symptom Relief
Greece · Duspatalin
Croatia · Colospa Retard, Rudakol
Ireland · Colofac, Mebeverine Hydrochloride Azure Pharmaceuticals
Iceland · Duspatalin Retard
Italy · Duspatal
Lithuania · Duspatalin, Mebeverine Sanoswiss
Luxembourg · Duspatalin, Duspatalin Retard
Latvia · Duspatalin, Mebeverine Sanoswiss
Malta · Colofac Retard, Mebeverine Hydrochloride Aspire Pharma (Malta)
Poland · Auroverin Mr, Duspatalin Gastro
Portugal · Duspatal Retard, Mebeverina Aristo
Romania · Colospasmin, Duspatalin
Slovenia · Rudakol
Slovakia · Duspatalin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c5721532-fffe-40c5-bb91-e4bc46084978
GET /v1/drugs/c5721532-fffe-40c5-bb91-e4bc46084978?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule met gereguleerde afgifte, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h11657_smpc.pdf",
  "strength": null,
  "atc_label": "Mebeverine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg11657",
  "excipients": [
    "AMMONIA (E 527)",
    "COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
    "COPOLYMEER VAN ETHYLACRYLAAT-METHYLMETHACRYLAAT (2:1) (E 1206)",
    "GELATINE (E 441)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "MEBEVERINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h11657.pdf",
  "authorised_at": "1987/08/12",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "11657",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about mebeverine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console